Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE HAUTES MARDELLES : revenue, balance sheet and financial ratios

SELARL PHARMACIE HAUTES MARDELLES is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BRUNOY (91800), this company of category PME shows in 2022 a net income positive of 220 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE HAUTES MARDELLES (SIREN 809176282)
Indicator 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 219 924 € 226 505 € 172 006 € 177 835 € 153 573 € 91 991 € 46 317 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2022, SELARL PHARMACIE HAUTES MARDELLES generates positive net income of 220 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 46 k€ -> 220 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

219 924 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 59%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

58.887%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.662%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

46.3%

Solvency indicators evolution
SELARL PHARMACIE HAUTES MARDELLES

Sector positioning

Debt ratio
58.89 2022
2020
2021
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Good +11 pts over 3 years

In 2022, the debt ratio of SELARL PHARMACIE HAUTES M... (58.89) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
45.66% 2022
2020
2021
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Average -17 pts over 3 years

In 2022, the financial autonomy of SELARL PHARMACIE HAUTES M... (45.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 200.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

200.776

Liquidity indicators evolution
SELARL PHARMACIE HAUTES MARDELLES

Sector positioning

Liquidity ratio
200.78 2022
2020
2021
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Good -20 pts over 3 years

In 2022, the liquidity ratio of SELARL PHARMACIE HAUTES M... (200.78) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE HAUTES MARDELLES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of SELARL PHARMACIE HAUTES MARDELLES is estimated at 2 587 737 € (range 1 739 473€ - 3 881 125€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
1739k€ 2587k€ 3881k€
2 587 737 € Range: 1 739 473€ - 3 881 125€
NAF 5 année 2022

Valuation method used

Net Income Multiple
219 924 € × 11.8x = 2 587 738 €
Range: 1 739 474€ - 3 881 126€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE HAUTES MARDELLES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE HAUTES MARDELLES

What is the revenue of SELARL PHARMACIE HAUTES MARDELLES ?

The revenue of SELARL PHARMACIE HAUTES MARDELLES is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE HAUTES MARDELLES profitable?

Yes, SELARL PHARMACIE HAUTES MARDELLES generated a net profit of 220 k€ in 2022.

Where is the headquarters of SELARL PHARMACIE HAUTES MARDELLES ?

The headquarters of SELARL PHARMACIE HAUTES MARDELLES is located in BRUNOY (91800), in the department Essonne.

Where to find the tax return of SELARL PHARMACIE HAUTES MARDELLES ?

The tax return of SELARL PHARMACIE HAUTES MARDELLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE HAUTES MARDELLES operate?

SELARL PHARMACIE HAUTES MARDELLES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.